Research output per year
Research output per year
Fingerprint
Dive into the research topics where Julian R Molina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib
Camidge, D. R., Moran, T., Demedts, I., Grosch, H., Mileham, K., Molina, J., Juan-Vidal, O., Bepler, G., Goldman, J. W., Park, K., Wallin, J., Wijayawardana, S. R., Wang, X. A., Wacheck, V. & Smit, E., Jun 2022, In: Clinical lung cancer. 23, 4, p. 300-310 11 p.Research output: Contribution to journal › Article › peer-review
-
Comparative analysis of predictive biomarkers for pd-1/pd-l1 inhibitors in cancers: Developments and challenges
Yang, F., Wang, J. F., Wang, Y., Liu, B. & Molina, J. R., Jan 1 2022, In: Cancers. 14, 1, 109.Research output: Contribution to journal › Review article › peer-review
Open Access -
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
Qiu, B., Cai, K., Chen, C., Chen, J., Chen, K. N., Chen, Q. X., Cheng, C., Dai, T. Y., Fan, J., Fan, Z., Hu, J., Hu, W. D., Huang, Y. C., Jiang, G. N., Jiang, J., Jiang, T., Jiao, W. J., Li, H. C., Li, Q., Liao, Y. D. & 58 others, , Sep 2021, In: Translational Lung Cancer Research. 10, 9, p. 3713-3736 24 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma
Leng, X., Wei, S., Mei, J., Deng, S., Yang, Z., Liu, Z., Guo, C., Deng, Y., Xia, L., Cheng, J., Zhao, K., Gan, F., Li, C., Merrell, K. W., Molina, J. R., Metro, G. & Liu, L., Feb 2021, In: Translational Lung Cancer Research. 10, 2, p. 966-980 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Quinacrine Has Preferential Anticancer Effects on Mesothelioma Cells With Inactivating NF2 Mutations
Oien, D. B., Sarkar Bhattacharya, S., Chien, J., Molina, J. & Shridhar, V., Sep 21 2021, In: Frontiers in Pharmacology. 12, 750352.Research output: Contribution to journal › Article › peer-review
Open Access